Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
To find out whether the BIA test can help identify participants with IBC who are at risk for developing lymphedema.
Full description
Primary Objectives The primary objective is to reliably describe risk factors for development of BCRL in IBC using BIA.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Eligibility Criteria All women≥18 years old with newly diagnosed inflammatory breast cancer without prior breast/axillary surgery who are eligible for standard of care (NST, MRM, and radiation therapy).
Exclusion Criteria Prior breast/axillary surgery. Participants with pacemakers or other implanted electronic medical devices. Participants with implanted metallic material. All vulnerable populations, including children, pregnant women, and cognitively impaired adult
Loading...
Central trial contact
Anthony Lucci, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal